Introduction
Materials and methods
Setting
Patients
Age, years
| 72 ± 12 |
Gender, % male
| 55 |
SOFA score
| 9.8 ± 2.8 |
APACHE II score
| 24.4 ± 5.4 |
APACHE II predicted risk mortality
| 50.8 ± 17.5 |
Actual mortality, %
| 50 |
Source of sepsis, n (%)
| |
Pneumonia | 9 (45) |
Intra-abdominal infection | 3 (15) |
Primary bacteremia | 3 (15) |
Endovascular infection | 2 (10) |
Cellulitis | 2 (10) |
Urinary tract infection | 1 (5) |
Fluid balance on the previous day, ml
| 4592 ± 3156 |
Fluid administration on the previous day, ml
| 6183 ± 2601 |
Measurements and derived calculations
Microvideoscopic measurements and analysis
Study protocol
Analysis of data
Results
Effects on hemodynamic and oxygen transport variables
Mean arterial blood pressure | ANOVA | Linear trend | |||
---|---|---|---|---|---|
65 mmHg | 75 mmHg | 85 mmHg |
P
|
P
| |
Norepinephrine doses (μg/kg/min)
| 0.48 ± 0.43 | 0.65 ± 0.68* | 0.74 ± 0.67* | < 0.0001 | < 0.0001 |
Heart rate (beats/min)
| 94 ± 21 | 92 ± 18 | 93 ± 18 | 0.59 | 0.43 |
Mean arterial blood pressure (mmHg)
| 65 ± 2 | 76 ± 2* | 85 ± 2* | < 0.0001 | < 0.0001 |
Mean pulmonary artery pressure (mmHg)
| 28 ± 7 | 30 ± 7* | 30 ± 7* | < 0.0001 | < 0.0001 |
Pulmonary artery occlusion pressure (mmHg)
| 14 ± 4 | 15 ± 4 | 16 ± 4 | 0.06 | 0.02 |
Central venous pressure (mmHg)
| 11 ± 4 | 12 ± 4 | 12 ± 4 | 0.18 | 0.47 |
Cardiac index (l/min/m
2
)
| 2.98 ± 0.99 | 3.11 ± 1.07 | 3.23 ± 1.02* | 0.0002 | < 0.0001 |
Oxygen transport (ml/min/m
2
)
| 366 ± 137 | 379 ± 145 | 383 ± 166 | 0.53 | 0.28 |
Oxygen consumption (ml/min/m
2
)
| 100 ± 33 | 91 ± 31 | 90 ± 40 | 0.61 | 0.63 |
Intramucosal-arterial pCO
2
(mmHg)
| 15 ± 15 | 16 ± 18* | 16 ± 18 | 0.03 | 0.06 |
Effects on lactate and acid-base parameters
Mean arterial blood pressure | ANOVA | Linear trend | |||
---|---|---|---|---|---|
65 mmHg | 75 mmHg | 85 mmHg |
P
|
P
| |
Arterial lactate (mmol/L)
| 2.6 ± 2.8 | 2.4 ± 2.7 | 2.5 ± 2.7 | 0.27 | 0.32 |
Hemoglobin (g%)
| 9.6 ± 2.3 | 9.6 ± 2.4 | 9.6 ± 2.3 | 0.76 | 0.79 |
Arterial pH
| 7.26 ± 0.11 | 7.26 ± 0.11 | 7.26 ± 0.11 | 0.44 | 0.29 |
Arterial PCO
2
(mmHg)
| 39 ± 10 | 39 ± 10 | 40 ± 11 | 0.73 | 0.57 |
Arterial PO
2
(mmHg)
| 112 ± 48 | 113 ± 45 | 108 ± 34 | 0.39 | 0.25 |
Arterial HCO
3
-
(mmol/l)
| 18 ± 5 | 18 ± 5 | 18 ± 5 | 0.50 | 0.43 |
Arterial oxygen saturation
| 0.96 ± 0.02 | 0.96 ± 0.02 | 0.96 ± 0.03 | 0.67 | 0.44 |
Mixed venous pH
| 7.23 ± 0.11 | 7.24 ± 0.10 | 7.24 ± 0.10 | 0.78 | 0.49 |
Mixed venous PCO
2
(mmHg)
| 45 ± 11 | 45 ± 11 | 45 ± 11 | 0.90 | 0.69 |
Mixed venous PO
2
(mmHg)
| 42 ± 7 | 43 ± 7 | 44 ± 8* | 0.04 | 0.02 |
Mixed venous HCO
3
-
(mmol/l)
| 19 ± 5 | 19 ± 5 | 19 ± 5 | 0.18 | 0.08 |
Mixed venous oxygen saturation
| 0.70 ± 0.08 | 0.72 ± 0.08* | 0.73 ± 0.07* | 0.01 | 0.005 |
Central venous oxygen saturation
| 0.74 ± 0.08 | 0.76 ± 0.08* | 0.77 ± 0.08* | 0.01 | 0.004 |
Arterial anion gap (mmol/L)
| 18 ± 6 | 19 ± 6 | 20 ± 7 | 0.16 | 0.06 |
Effects on gastric tonometry
Effects on sublingual microcirculation
Mean arterial blood pressure | ANOVA | Linear trend | |||
---|---|---|---|---|---|
65 mmHg | 75 mmHg | 85 mmHg |
P
| P | |
Vascular density (vessels/mm2) | |||||
Large diameter vessels | 11 ± 1 | 10 ± 3 | 10 ± 3 | 0.81 | 0.61 |
Medium diameter vessels | 15 ± 3 | 16 ± 4 | 16 ± 4 | 0.82 | 0.53 |
Small diameter vessels | 24 ± 8 | 23 ± 8 | 22 ± 1 | 0.09 | 0.03 |
Microvascular flow index | |||||
Large diameter vessels | 2.3 ± 0.6 | 2.3 ± 0.8 | 2.2 ± 0.8 | 0.34 | 0.16 |
Medium diameter vessels | 2.2 ± 0.7 | 2.2 ± 0.7 | 2.1 ± 0.9 | 0.79 | 0.52 |
Small diameter vessels | 2.1 ± 0.7 | 2.2 ± 0.7 | 2.0 ± 0.8 | 0.69 | 0.47 |
Perfused vessels (%) | |||||
Large diameter vessels | 82 ± 21 | 80 ± 28 | 87 ± 6 | 0.46 | 0.40 |
Medium diameter vessels | 77 ± 27 | 77 ± 29 | 77 ± 6 | 0.98 | 1.00 |
Small diameter vessels | 72 ± 26 | 71 ± 27 | 67 ± 32 | 0.55 | 0.38 |
Total vessels | 75 ± 25 | 75 ± 27 | 76 ± 4 | 0.92 | 0.73 |
Heterogeneity flow index | |||||
Large diameter vessels | 1.0 ± 0.5 | 1.3 ± 1.2 | 1.5 ± 1.4 | 0.07 | 0.02 |
Medium diameter vessels | 1.6 ± 1.6 | 1.5 ± 1.4 | 1.7 ± 1.2 | 0.86 | 0.78 |
Small diameter vessels | 1.8 ± 1.3 | 1.8 ± 1.2 | 1.7 ± 1.1 | 0.97 | 0.80 |
Discussion
Conclusions
Key messages
-
Patients with septic shock showed severe microcirculatory abnormalities that an increase in MAP with norepinephrine globally failed to improve.
-
The change in the perfused capillary density was strongly dependent on the basal state of the microcirculation. Thus, perfused capillary density improved in patients with an altered sublingual perfusion at baseline, and decreased in patients with preserved basal microvascular perfusion.